Defining the genetic architecture of hypertrophic cardiomyopathy: Re-evaluating the role of non-sarcomeric genes
10.1093/eurheartj/ehw603
Saved in:
Main Authors: | Walsh R., Buchan R., Wilk A., John S., Felkin L.E., Thomson K.L., Chiaw T.H., Loong C.C.W., Pua C.J., Raphael C., Prasad S., Barton P.J., Funke B., Watkins H., Ware J.S., Cook S.A. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
Oxford University Press
2019
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/150641 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center
by: Mazzarotto F., et al.
Published: (2019) -
Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: The case of hypertrophic cardiomyopathy
by: Walsh, R., et al.
Published: (2021) -
Hypertrophic Cardiomyopathy: From Genes to Bedside
by: Objoon Trachoo, et al.
Published: (2022) -
A comparative study of mutation screening of sarcomeric genes (MYBPC3, MYH7, TNNT2) using single gene approach versus targeted gene panel next generation sequencing in a cohort of HCM patients in Egypt
by: Kassem H.S., et al.
Published: (2019) -
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples
by: Walsh R., et al.
Published: (2019)